Pfizer and Merck discontinue Phase 3 avelumab ovarian cancer trial httpbit.ly2Fi8EVd pharma cancer OvarianCancer

Pfizer and Merck discontinue Phase 3 avelumab ovarian cancer trial http://bit.ly/2Fi8EVd  #pharma #cancer #OvarianCancer

13:45 EDT 20 Mar 2019 | Pharmafile

Pfizer and Merck discontinue Phase 3 avelumab ovarian cancer trial http://bit.ly/2Fi8EVd  #pharma #cancer #OvarianCancer

More From BioPortfolio on "Pfizer and Merck discontinue Phase 3 avelumab ovarian cancer trial http://bit.ly/2Fi8EVd  #pharma #cancer #OvarianCancer"